Pharmspective Launches Accessai Market Access Artificial Intelligence Platform

By Author: Orson Amiri
Total Articles: 401
Comment this article

Pharmspective LLC has launched AccessAI™, the first artificial intelligence (AI) tool designed to streamline Market Access knowledge acquisition in the biopharmaceutical industry. AccessAI™ integrates AI technology with a foundation of over 12,000 curated and vetted references from diverse data sources, updated daily. It covers topics such as insurers, reimbursement, delivery channels, distribution, payment models, policy, and access dynamics impacting pharmaceutical manufacturers. The web-enabled, subscription-based portal simplifies market access research, offering a faster and more cost-effective solution compared to traditional approaches. With a dedicated Content Management team, AccessAI™ aims to enhance efficiency for Payer Insights teams, Account Management, Payer Marketing, and Access Strategy units. The platform leverages AI chatbots to generate high-quality market research efficiently.

Read More - https://www.techdogs.com/tech-news/pr-newswire/pharmspective-launches-accessai-market-access-artificial-intelligence-platform